GSK Has Generalized Anxiety For Paxil, Augmented Patent For Augmentin
Executive Summary
GlaxoSmithKline is initiating direct-to-consumer advertising to support Paxil for generalized anxiety disorder to coincide with the market entrance of the first generic versions of Prozac.
You may also be interested in...
GSK returns gemifloxacin rights
GlaxoSmithKline will return worldwide rights to quinolone antibiotic Factive (gemifloxacin) to development partner LG Chemicals Investments. Factive was deemed "not approvable" by FDA at the end of 2000 (1"The Pink Sheet" July 30, 2001, p. 20)...
GSK returns gemifloxacin rights
GlaxoSmithKline will return worldwide rights to quinolone antibiotic Factive (gemifloxacin) to development partner LG Chemicals Investments. Factive was deemed "not approvable" by FDA at the end of 2000 (1"The Pink Sheet" July 30, 2001, p. 20)...
PhRMA Anthrax Brochure Includes Off-Label Information Disclaimer
The Pharmaceutical Research & Manufacturers of America's anthrax educational brochure includes a disclaimer that the information has not been approved by FDA